Abstract | OBJECTIVE: METHODS: RESULTS: The Hyp content and the expressions of collagen type I, TGF-beta1, TbetaRI and TbetaRII in the liver tissue of rats in the untreated group increased significantly as compared with those in the normal control group, while those in SA-B-treated group decreased significantly as compared with those in the untreated group. CONCLUSION: The therapeutic mechanism of SA-B in treating hepatic fibrosis may be related to inhibiting the expressions of TGF-beta1 and its receptors.
|
Authors | Xiao-Ning Wang, Yi-Yang Hu, Cheng-Hai Liu, Ping Liu, Da-Yuan Zhu |
Journal | Zhong xi yi jie he xue bao = Journal of Chinese integrative medicine
(Zhong Xi Yi Jie He Xue Bao)
Vol. 3
Issue 4
Pg. 286-9
(Jul 2005)
ISSN: 1672-1977 [Print] China |
PMID | 16009107
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Benzofurans
- Collagen Type I
- Receptors, Transforming Growth Factor beta
- TGFB1 protein, human
- Tgfb1 protein, rat
- Transforming Growth Factor beta
- Transforming Growth Factor beta1
- salvianolic acid B
- Protein Serine-Threonine Kinases
- Receptor, Transforming Growth Factor-beta Type II
- Dimethylnitrosamine
- Hydroxyproline
|
Topics |
- Animals
- Benzofurans
(pharmacology)
- Collagen Type I
(analysis)
- Dimethylnitrosamine
- Hydroxyproline
(analysis)
- Liver
(metabolism)
- Liver Cirrhosis, Experimental
(chemically induced, metabolism)
- Male
- Protein Serine-Threonine Kinases
- Random Allocation
- Rats
- Rats, Wistar
- Receptor, Transforming Growth Factor-beta Type II
- Receptors, Transforming Growth Factor beta
(biosynthesis, genetics)
- Transforming Growth Factor beta
(biosynthesis, genetics)
- Transforming Growth Factor beta1
|